Decitabine reactivated pathways in platinum resistant ovarian cancer

Combination therapy with decitabine, a DNMTi and carboplatin resensitized chemoresistant ovarian cancer (OC) to platinum inducing promising clinical activity. We investigated gene-expression profiles in tumor biopsies to identify decitabine-reactivated pathways associated with clinical response. Gen...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Fang, Fang, Zuo, Qingyao, Pilrose, Jay, Wang, Yinu, Shen, Changyu, Li, Meng, Wulfridge, Phillip, Matei, Daniela, Nephew, Kenneth P.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2014
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116504/
https://ncbi.nlm.nih.gov/pubmed/25003579
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items